Literature DB >> 23911358

Upregulation of the inhibitory receptor ILT4 in monocytes from septic patients.

Eleonora Baffari1, Diego Fiume, Giordana Caiazzo, Anna Sinistro, Silvia Natoli, Cristiana Almerighi, Francesca Calò-Carducci, Francesca Leonardis, Alberto Bergamini.   

Abstract

Sepsis-induced immune dysfunction is a complex phenomenon that involves both innate and adaptive responses. Upregulation of the inhibitor receptor named immunoglobulin like transcript 4 (ILT4) is crucial to the tolerogenic function of monocytes. Here, ILT4 expression, endotoxin-induced IL-12 and IL-10 production and CD86 expression were investigated in circulating monocytes from 16 patients with severe sepsis and 16 age and sex matched controls. We found that monocytes from patients with severe sepsis express significantly higher levels of ILT4 than monocytes from controls. Upregulation of ILT4 expression appeared to be induced by soluble factors present in the serum of septic patients and directly correlated with the degree of organ dysfunction. ILT4(+) monocytes from septic patients also displayed an alteration in the cytokine response to endotoxin stimulation characterized by reduced IL-12 production and increased IL-10 production, and a reduced expression of the costimulatory molecule CD86. In conclusion, the increased ILT4 expression and IL-10 production and the decreased CD86 expression and IL-12 production indicate that during sepsis monocytes undergo substantial modulation of the surface and cytokine phenotype. These phenotypic changes may interfere with the antigen presenting cell activity of monocytes, which may contribute to the impairment of adaptive immune responses that takes place during sepsis.
Copyright © 2013 American Society for Histocompatibility and Immunogenetics. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  APC; FITC; ILT4; LPS; PBMC; PC5; PE; R-phycoerythrin-cyanine; SAPS II; SOFA; Sequential Organ Failure Assessment score; Simplified Acute Physiology score; antigen presenting cell; fluorescein isothiocyanate; immunoglobulin like transcript 4; lipopolysaccharide; peripheral blood mononuclear cells; phycoerythrin

Mesh:

Substances:

Year:  2013        PMID: 23911358     DOI: 10.1016/j.humimm.2013.07.012

Source DB:  PubMed          Journal:  Hum Immunol        ISSN: 0198-8859            Impact factor:   2.850


  5 in total

1.  ANGPTL2/LILRB2 signaling promotes the propagation of lung cancer cells.

Authors:  Xiaoye Liu; Xiaoting Yu; Jingjing Xie; Mengna Zhan; Zhuo Yu; Li Xie; Hongxiang Zeng; Feifei Zhang; Guoqiang Chen; Xianghua Yi; Junke Zheng
Journal:  Oncotarget       Date:  2015-08-28

2.  Downregulation of immunoglobulin-like transcript-4 (ILT4) in patients with psoriatic arthritis.

Authors:  Alberto Bergamini; Maria Sole Chimenti; Eleonora Baffari; Maria Domenica Guarino; Gianfranco Gigliucci; Carlo Perricone; Roberto Perricone
Journal:  PLoS One       Date:  2014-03-27       Impact factor: 3.240

3.  Interleukin-6 is a key factor for immunoglobulin-like transcript-4-mediated immune injury in sepsis.

Authors:  De Wen Zhang; Jian He
Journal:  J Intensive Care       Date:  2018-04-10

Review 4.  Leukocyte Immunoglobulin-Like Receptors in Regulating the Immune Response in Infectious Diseases: A Window of Opportunity to Pathogen Persistence and a Sound Target in Therapeutics.

Authors:  Florence Abdallah; Sixtine Coindre; Margaux Gardet; Florian Meurisse; Abderrahim Naji; Narufumi Suganuma; Laurent Abi-Rached; Olivier Lambotte; Benoit Favier
Journal:  Front Immunol       Date:  2021-09-14       Impact factor: 7.561

Review 5.  Detection of Immune Checkpoint Receptors - A Current Challenge in Clinical Flow Cytometry.

Authors:  Benjamin Shibru; Katharina Fey; Stephan Fricke; André-René Blaudszun; Friederike Fürst; Max Weise; Sabine Seiffert; Maria Katharina Weyh; Ulrike Köhl; Ulrich Sack; Andreas Boldt
Journal:  Front Immunol       Date:  2021-07-01       Impact factor: 7.561

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.